Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Cellectis S.A.
  6. News
  7. Summary
    ALCLS   FR0010425595

CELLECTIS S.A.

(ALCLS)
  Report
Real-time Euronext Paris  -  08:29 2022-12-05 am EST
2.182 EUR   +0.93%
12/01Cellectis to Host a Live Webcast and Provide a Company Update on December 13, 2022
GL
11/30European Equities Nudge Higher on Slightly Lower Euro Area Inflation
MT
11/30Cellectis S A : Document AMF CP. 2022E873929
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Biopharmaceutical Group Cellectis Hires Chief Medical Officer

09/29/2022 | 01:07am EST


© MT Newswires 2022
All news about CELLECTIS S.A.
12/01Cellectis to Host a Live Webcast and Provide a Company Update on December 13, 2022
GL
11/30European Equities Nudge Higher on Slightly Lower Euro Area Inflation
MT
11/30Cellectis S A : Document AMF CP. 2022E873929
PU
11/24Cellectis S A : Document AMF CP. 2022E873261
PU
11/21Cellectis S A : Document AMF CP. 2022E872622
PU
11/18Cellectis S A : Document AMF CP. 2022E872470
PU
11/16European Equities Flat in Choppy Trade Wednesday as Geopolitical Tensions Weigh
MT
11/11Cellectis Publishes Manuscript in Frontiers Bioengineering and Biotechnology Unveiling ..
AQ
11/11Cellectis Presents Pre-Clinical Data on TALEN-edited Smart CAR T-cells Overcoming Key C..
AQ
11/10European ADRs Surge Higher as Global Markets React to US Inflation Data
MT
More news
Analyst Recommendations on CELLECTIS S.A.
More recommendations
Financials
Sales 2022 28,0 M 29,4 M 29,4 M
Net income 2022 -101 M -105 M -105 M
Net cash 2022 26,8 M 28,1 M 28,1 M
P/E ratio 2022 -0,58x
Yield 2022 -
Capitalization 98,5 M 103 M 103 M
EV / Sales 2022 2,56x
EV / Sales 2023 2,81x
Nbr of Employees 297
Free-Float 99,8%
Chart CELLECTIS S.A.
Duration : Period :
Cellectis S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CELLECTIS S.A.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 2,16
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
André Choulika Chief Executive Officer & Director
Bing C. Wang Chief Financial Officer
Jean-Pierre Garnier Non-Executive Chairman
Philippe Duchateau Chief Scientific Officer
Mark Frattini Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
CELLECTIS S.A.-70.94%103
MODERNA, INC.-28.20%70 055
IQVIA HOLDINGS INC.-22.83%40 441
LONZA GROUP AG-33.82%39 802
ALNYLAM PHARMACEUTICALS, INC.38.22%28 838
SEAGEN INC.-20.82%22 727